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Available online 28 December 2015Most studies investigating the biology of Hepatitis C virus (HCV) have used the human hepatoma cell line Huh-7 or
subclones thereof, as these are themost permissive cell lines forHCV infection and replication. Other cell lines also sup-
port replication of HCV,most notably the human hepatoblastoma cell line HuH6. HCV replication in cell culture is gen-
erally highly sensitive to interferons (IFNs) and differences in the IFN-mediated inhibition of virus replication may
reﬂect alterations in the IFN-induced antiviral response inherent to different host cells. For example, HCV replication
is highly sensitive to IFN-γ treatment in Huh-7, but not in HuH6 cells. In this study, we used microarray-based gene
expression proﬁling to compare the response of Huh-7 and HuH6 cells to stimulation with IFN-α and IFN-γ. Further-
more, we determined whether the resistance of HCV replication in HuH6 cells can be linked to differences in the ex-
pression proﬁle of IFN-regulated genes. Although both cells lines responded to IFNs with rapid changes in gene
expression, thereby demonstrating functional type I and type II signaling pathways, differences were observed for a
number of genes. Raw and normalized expression data have been deposited in GEO under accession number
GSE68927.
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. This is an open access article under2. Experimental design, materials and methods
2.1. Cell culture experiments and RNA isolation
The hepatoma cell line Huh-7 is themost commonly used cell line to
study the biology of the human pathogen Hepatitis C virus (HCV) [1]. In
these cells, HCV replication is strongly inhibited by both interferon-α
(IFN-α) [2] as well as interferon-γ (IFN-γ) [3]. In the hepatoblastoma
cell line HuH6, however, HCV replication is largely resistant to
treatment with IFN-γ but not IFN-α [4]. To analyze the IFN-γ and IFN-
α response in Huh-7 and HuH6 cells, we decided to perform a
microarray-based gene expression analysis. To this end, Huh-7 and
HuH6 cells, that were grown in Dulbecco's modiﬁed minimal essential
medium (Life Technologies, Karlsruhe, Germany) supplemented with
10% fetal calf serum, 2 mM L-glutamine, nonessential amino acids,
100 U of penicillin G/mL, and 100 μg of streptomycin/mL at 37 °C
and 5% CO2, were plated in 10-cm cell culture petri dishes at 80% cell
conﬂuence and treated with either 1000 IU/mL IFNα-2a (PBL Laborato-
ries, Acris, Herford, Germany), 1000 IU/mL IFN-γ (Roche, Basel,
Switzerland), or remained untreated for 24 h. Total RNA was extractedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Number of IFN-induced genes in Huh-7 versus HuH6 cells. ISGs were deﬁned
as being at least 1.5-fold upregulated and being “present” upon IFN-treatment. Venn
diagrams were generated using BioVenn (http://www.cmbi.ru.nl/cdd/biovenn/) [9].
Table 1
Top20 induced ISGs upon IFN treatment inHuh-7 andHuH6 cells. ISGswere sorted for the
magnitude of their induction (fold-change, FC) within each sample. The 20 genes
most strongly induced by IFN-α (left) or IFN-γ (right) are listed for Huh-7 and HuH6, re-
spectively. Fold-changes are given on a log2 scale (i.e. FC 7.35 translates to a 163-fold
upregulation).
IFN-α IFN-γ
Gene
symbol
FC
Huh-7
Gene
symbol
FC
HuH6
Gene
symbol
FC
Huh-7
Gene
symbol
FC
HuH6
MX1 7.35 IFIT1 8.4 GBP1 8.46 GBP1 6.55
IFIT1 6.93 CMPK2 7.3 PSMB9 7.49 PSMB9 6.04
CMPK2 5.93 IFI27 6.91 TAP1 5.85 UBE2L6 6.01
DDX60 5.9 IFI44L 6.25 PSMB8 5.74 GBP3 5.72
IFI6 5.82 IFIH1 5.99 RARRES3 5.67 TAP1 5.37
IFIH1 5.81 DDX60 5.62 UBD 5.58 TRIM22 5.21
IFIT3 5.33 OAS3 5.6 GBP3 5.1 NMI 4.97
ISG15 5.21 IFI6 5.56 IFIT3 5.04 RARRES3 4.75
OAS1 5.17 IFIT3 5.37 EPSTI1 4.97 ERAP2 4.75
OAS3 4.92 OAS1 5.11 CXCL10 4.62 CMPK2 4.69
HERC6 4.84 IFI44 4.92 DDX60 4.29 UBD 4.62
EPSTI1 4.79 IFIT5 4.47 NNMT 4.28 SERPING1 4.5
IRF9 4.2 UBE2L6 4.4 UBE2L6 4.23 IFI27 4.5
OAS2 4.13 OAS2 4.37 TRIM22 3.81 IFIT3 4.45
IFI27 4.11 ISG15 4.03 PARP14 3.78 PSMB8 4.12
DDX58 3.8 DTX3L 3.86 CXCL9 3.74 DTX3L 3.88
DDX60L 3.62 DDX58 3.8 IRF9 3.67 PARP14 3.53
IFITM1 3.55 HERC6 3.48 LGALS3BP 3.59 PARP9 3.47
IFI44L 3.44 IRF9 3.43 IFIH1 3.47 BATF2 3.4
LGALS3BP 3.42 PARP9 3.42 CXCL11 3.44 DDX60 3.37
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conﬁrmed by agarose gel electrophoresis and RNA concentration was
determined by measurement of OD at 260 nm on a NanoDrop Lite
(Thermo Scientiﬁc, Braunschweig, Germany).
2.2. Microarray experiments
For ﬁrst-strand cDNA synthesis, 13.5 μg total RNA was incubated as
published before [6] with polyadenylated control RNAs and T7-oligo
(dT)24 primer [5′-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGG
CGG-(dT24)-3′] at 70 °C for 10 min and put on ice. Next, the ﬁrst-
strand buffer mix (4 μL of 5× the ﬁrst-strand buffer, 2 μL 0.1 M dithio-
threitol (DTT), and 1 μL 10 mM dNTPs) was preincubated at 42 °C for
2 min. After addition of 2 μL (200 units) Superscript II (Life Technolo-
gies, Karlsruhe, Germany), incubation was continued at 42 °C for 1 h.
For second-strand synthesis, 30 μL 5× the second-strand buffer, 91 μL
RNase-free water, 3 μL 10 mM dNTPs, 4 μL (40 U) Escherichia coli DNA
polymerase I (Life Technologies), 1 μL (12 U) E. coli DNAligase (TaKaRa,
Gennevilliers, France), and 1 μL (2 U) RNase H (TaKaRa) were added,
and the mix was incubated at 16 °C for 2 h. Then 2.5 μL (10 U) T4 DNA
polymerase I (TaKaRa) were added at 16 °C for 5 min. The reaction
was stopped by the addition of 10 μL 0.5 M EDTA, double-stranded
(ds) cDNA was extracted with phenol/chloroform, and the aqueous
phase was recovered by phase-lock gel separation (Eppendorf, Ham-
burg, Germany). After precipitation, the cDNA was restored in 12 μL
RNase-free water. Five microliters ds cDNA were used to synthesize bi-
otinylated cRNA using the BioArray High Yield RNA Transcript Labeling
Kit (Enzo Diagnostics, NY). Labeled cRNAwas puriﬁed using the RNeasy
Mini Kit (Qiagen,Hilden,Germany). Fragmentation andhybridization of
10 μg cRNA to GeneChip HG-U133 Plus 2.0 microarrays (Affymetrix,
Santa Clara, CA) for 16 h at 45 °C, as well as washing and staining on a
Fluidics Station 450 (Affymetrix), and scanning of the arrays in a
GeneArray Scanner 2500 (Agilent, Palo Alto, CA) were performed ac-
cording to the Affymetrix Gene Expression Analysis Technical Manual.
2.3. Signal processing and normalization
Raw Affymetrix data (.CEL-ﬁles) were further processed using the
Chipster software, version 3.4.0 [7]. Signals were normalized within
one cell line (three treatment groups per cell line: mock, IFN-α and
IFN-γ) using the RMA method and expressed on a log2-transformed
scale. Probe-sets were remapped to 19,674 Entrez Gene IDs using a cus-
tomCDF ﬁle (version 12, Thompson andMengmicroarray lab, Universi-
ty of Michigan) [8] and expression calls (A: absent, M: moderate, or P:
present) were calculated using the MAS5 algorithm. Without further
processing and ﬁltering, data for Huh-7 and HuH6 cells were merged
and exported into an Excel ﬁle for user-friendly interactive ﬁltering
(Supplementary data ﬁle 1).
2.4. Analysis of IFN-induced genes
Albeit genes induced by IFN, termed IFN-stimulated genes (ISGs),
have been deﬁned and known for a long time (e.g. http://www.
interferome.org [10]) [11–21], the exact set and number of genes that
are regulated by IFN varies between different cell types and might sub-
stantially affect the cells' capacity to interfere with the replication of
speciﬁc viruses. We therefore compared the ISG proﬁle of the two
hepatocyte-derived cell lines Huh-7 and HuH6, which are widely
employed for research on hepatitis viruses, especially Hepatitis C virus
(HCV). For this analysis, we deﬁned ISGs as (1) being called “present”
in the IFN-treated sample and (2) being upregulated at least 1.5-fold
(0.58 on a log2-scale) upon IFN-treatment. For IFN-α, we found 269
ISGs in Huh-7 and 109 ISGs in HuH6, with 81 being common to both
(Fig. 1). For IFN-γ, we found 207 ISGs in Huh-7 and 202 in HuH6, with
112 genes in common to both cell lines (Fig. 1). The genes that were
most strongly induced upon IFN-α treatment in both cell lines includewell-known prototype ISGs, such as MX1, IFIT1 (ISG56), IFIT3, IFI6 and
OAS1-3 (Table 1). For IFN-γ, too, well-established prototype ISGs were
strongly upregulated, such as GBP1, GBP3 or TAP1 (Table 1).
2.5. ISGs differentially induced in Huh-7 versus HuH6
We then analyzed the induced ISG proﬁles of the two cell lines for
differentially regulated genes, i.e. genes whose transcriptional regula-
tion upon IFN-treatment is signiﬁcantly different between Huh-7 and
HuH6. For this analysis, we deﬁned IFN-α or IFN-γ ISGs as being “pres-
ent” and upregulated by at least 1.5-fold in either Huh-7 or HuH6 upon
treatment with the respective IFN, resulting in 301 ISGs for IFN-α and
292 ISGs for IFN-γ (excluding Affymetrix controls, see Supplementary
data ﬁle 1). To generate ISG proﬁles for Huh-7 and HuH6, ISGs were
then ranked based on their fold-change within the respective cell line,
with rank 1 being awarded to the gene with highest induction. Plotting
the ranked proﬁles against each other allows for easy visual identiﬁca-
tion of the ISGs most strongly differing in their regulation between
Huh-7 and HuH6 (Fig. 2). Surprisingly, for IFN-α, MX1, being one of
the most strongly induced and best characterized ISGs, only ranks
Fig. 2. Correlation of ISGs induced in Huh-7 and HuH6. ISGs were ranked by their respective induction upon IFN-treatment (fold-change); rank 1 corresponds to the highest induction.
Ranks in Huh-7 were plotted against ranks in HuH6. Genes were color-coded according to their weighted rank difference (WRD) and genes with high WRD values are labeled.
168 O. Grünvogel et al. / Genomics Data 7 (2016) 166–17056th in HuH6 (rank 1 in Huh-7), whereas IFI44 is a top-ISG in HuH6
(rank 11) but hardly induced in Huh-7 (rank 277). Further, CXCL-type
chemokines CXCL1 (Gro-α), CXCL2 (Gro-β) and CXCL10 (IP-10) are up-
regulated inHuh-7,whereas they are not induced inHuH6 (Fig. 2). For IFN-
γ, theCXCLchemokines, inparticular CXCL10and11, are again stronglyup-
regulated in Huh-7 (ranking 10th and 20th, respectively) and only to aTable 2
ISGs differentially induced in Huh-7 versus HuH6. ISGs were deﬁned as “present” and upregu
weighted rank difference (WRD). Highest WRD corresponds to the strongest difference in indu
IFN-α
Gene symbol FC Huh-7 FC HuH6 rank Huh-7 rank HuH6 WRD
MX1 7.35 1.49 1 56 1.93
IFI44 0.47 4.92 277 11 1.85
TDO2 3.07 −0.19 27 287 1.66
IFI16 0.06 2.56 290 35 1.57
GBP1 3.11 0.19 25 178 1.51
SLFN5 0.08 1.66 287 49 1.42
RASGRP3 0.68 2.13 204 39 1.36
IL8 1.7 −0.36 59 301 1.34
IFI27 4.11 6.91 15 3 1.33
LY6E −0.29 1.4 303 61 1.33
UBD 3.04 0.33 29 143 1.33
IFI44L 3.44 6.25 19 4 1.30
CARD16 1.59 −0.28 64 297 1.29
CXCL2 1.89 −0.01 56 241 1.25
CXCL10 1.75 −0.03 58 246 1.24
MX2 0.23 1.23 282 67 1.23
CASP7 0.64 1.44 232 59 1.19
HERC5 3.11 0.77 25 95 1.17
CXCL5 1.38 −0.15 74 280 1.16
LOC100506113 −0.08 0.92 298 80 1.15
RARRES3 2.12 0.22 47 167 1.12
MYH4 1.29 −0.2 82 289 1.12
SLC26A3 1.34 −0.14 80 278 1.11
ERAP2 −0.04 0.86 294 85 1.10
TAP2 0.58 0.92 273 80 1.09
PROCR −0.06 0.82 296 88 1.08
SH3BGRL −0.07 0.81 297 89 1.08
B3GALT2 1.37 −0.05 76 253 1.08
BTN3A2 2.08 0.24 49 161 1.07
HSH2D −0.23 0.78 302 92 1.07
EREG 1.63 0.14 62 200 1.05
SERPING1 0.71 1.41 192 60 1.05
LAMP3 3.23 1.09 23 72 1.03
CCR6 0.12 0.78 285 92 1.02
MT1M 1.15 −0.46 99 303 1.01
KLF10 1.19 −0.19 94 287 1.01
LOC731779 −0.2 0.71 300 99 1.01much lesser extend in HuH6 (ranking above 100). Further, the MHC
genes HLA-A, B and C are strongly induced in Huh-7 but substantially less
so in HuH6. Conversely, IFI27 (rank 12) and ERAP2 (rank 8) are prominent
ISGs in HuH6 but not in Huh-7 (ranking above 100).
As a quantitative measure to score differentially induced ISGs, we
calculated a weighted rank difference (WRD) for each gene. The WRDlated at least 1.5-fold (0.58 on a log2 scale) in either Huh-7 or HuH6 and sorted for their
ction between Huh-7 and HuH6 (see text). FC: fold-change (log2 scale).
IFN-γ
Gene symbol FC Huh-7 FC HuH6 rank Huh-7 rank HuH6 WRD
ERAP2 1.08 4.75 126 8 1.76
CXCL9 3.74 0.31 16 234 1.74
BTN3A3 3.28 0.04 23 265 1.68
MX1 3.16 −0.1 26 285 1.67
CXCL10 4.62 1.06 10 103 1.65
CARD16 3.27 0.24 24 243 1.64
IFI27 1.21 4.5 111 12 1.61
APOL3 0.37 2.84 228 30 1.53
CASP1 2.69 0.02 42 268 1.46
NMI 2.61 4.97 43 7 1.44
HLA-B 2.75 0.21 40 245 1.44
CXCL11 3.44 0.88 20 122 1.44
CASP7 0.69 2.8 184 31 1.42
CTSS 2.57 0.34 45 232 1.35
IFI16 0 1.98 268 53 1.34
HERC6 2.59 0.43 44 219 1.33
C1R 3.06 0.75 29 141 1.32
EPSTI1 4.97 2.42 9 43 1.31
CFH 2.35 0.13 54 254 1.30
CXCL2 1.99 −0.26 65 292 1.27
UBE2L6 4.23 6.01 13 3 1.25
SERPINA7 1.95 −0.34 69 296 1.24
SERPING1 2.45 4.5 51 12 1.24
ARAP2 0.21 1.76 250 61 1.22
GNB4 0.5 1.89 217 56 1.18
LGALS3BP 3.59 1.53 18 69 1.17
HLA-A 2.03 0.29 63 237 1.16
PSMB8 5.74 4.12 4 15 1.16
NCOA7 0.42 1.79 224 60 1.15
IL7 1.97 0.17 67 249 1.15
NLRC5 1.87 −0.03 74 275 1.15
APOBEC3G 0.19 1.56 251 68 1.15
CD274 2.15 0.58 60 210 1.11
TRIM31 1.8 0 79 271 1.10
TLR3 1.75 −0.06 82 280 1.09
RASGRP3 0.38 1.64 225 66 1.09
LAMP3 1.78 0.01 80 269 1.08
DDX60L 1.68 −0.07 85 282 1.07
ACY3 1.91 0.29 73 237 1.06
TAPSAR1 3.01 1.12 30 94 1.03
169O. Grünvogel et al. / Genomics Data 7 (2016) 166–170was deﬁned as the difference in a gene's rank between Huh-7 and
HuH6, normalized to the gene's mean rank: WRD ¼ jrHuH6−rHuh−7 j1=2ðrHuH6þrHuh−7Þ
(with rn being the rank in the respective cell line), and therefore
0 ≤WRD b 2. Normalization to the mean rank accounts for the increas-
ingpossible variation for lower ranks; simply put, a rank difference of 50
is less signiﬁcant in case of a gene ranking 250th and 300th (WRD =
0.18) as compared to a gene ranking 1st and 51st (WRD = 1.92).
Table 2 lists the most signiﬁcant (WRD N 1) differentially regulated
ISGs between Huh-7 and HuH6 for IFN-α and IFN-γ in Huh-7 (full list
of ISGs with WRDs in Supplementary data ﬁle 1).3. Discussion
In this study, we describe the experimental details used to compare
the IFN-induced changes in gene expression in the two human liver de-
rived cell lines Huh-7 and HuH6. A large number of genes have been
classiﬁed as ISGs in the past [11–21]. The ISG database http://www.
interferome.org [10] currently lists 3185 type I IFN regulated human
genes in total, however with substantial differences between different
cell or tissue types. For non-immune cells lines, typically 200 to 400
genes are upregulated robustly by IFN [14–17,20], depending on the
chosen cut-off. This is in good agreement with our ﬁndings for Huh-7
(IFN-α: 269; IFN-γ: 207 genes N 1.5-fold) and HuH6 (IFN-α: 109; IFN-
γ: 202 genes N 1.5-fold). Moreover, the genes that were most strongly
upregulated in both cell lines (see Table 1) comprise prominent ISGs
found in various earlier studies [11–21]; of the 20 highest ranking
ISGs induced by IFN-α in our study, 16 (Huh-7) or 17 (HuH6) can be
found in the manually curated list of ISGs described by Schoggins and
colleagues [20]. Remarkably, IFN-α induced more ISGs in Huh-7 cells
than in HuH6 cells. The reason for this apparent lack of IFN-α-
stimulated ISGs in HuH6 cells likely reﬂects the arbitrary cutoff of 1.5-
fold upregulation used to identify ISGs. However, comparing the
269 ISGs from Huh-7 to the 269 most upregulated genes in HuH6
(disregarding the fold-change cutoff) it only marginally increases
the overlap between the two cell lines from 88 genes (see Fig. 1) to
102 genes, with the remaining 167 being unique to Huh-7 or HuH6, re-
spectively. This argues against the hypothesis that HuH6 has a similar
ISG proﬁle, but lower overall induction values. In fact, the most strongly
induced ISGs exhibit comparable fold-inductions in both cell lines
(see Table 1). Furthermore, the ability of HuH6 cells to mount a func-
tional antiviral response is not compromised in general, as these cells
are capable to inhibit the replication of several viruses upon treatment
with IFN-α [4]. In contrast to type I IFN, the number of genes induced
upon IFN-γ treatment (by at least 1.5-fold) was similar in Huh-7 and
HuH6 cells, and the overlap of induced genes was more substantial
(see Fig. 1). Nonetheless, even for IFN-γ, roughly half of the ISGs were
unique to the respective cell line, again highlighting the cell-type
dependence of the induced ISG proﬁle.
In order to speciﬁcally analyze differences between the ISG proﬁles
of Huh-7 and HuH6, we used a ranked list approach, screening for
those genes, whose rank differed most between the two proﬁles.
These differentially regulated genes represent highly interesting candi-
dates for future studies on functional differences between the IFN re-
sponse in Huh-7 and HuH6 cells. For example, it has been shown
before, that the IFN-γ response in HuH6 – in contrast to Huh-7 – cells
is not capable to efﬁciently inhibit the replication of HCV [4]. In fact,
we could show that one of the genes identiﬁed as being differentially
regulated by IFN-γ in the two cell lines, DDX60L (WRD = 1.07, see
Table 2), functionally contributes to this resistance phenotype of HCV
in IFN-γ treated HuH6 cells [22].
The underlying reasons for the observed profound differences in the
ISG proﬁles between Huh-7 and HuH6 cells and previously observed
differences between other cell types remain largely elusive [11–21].
Subtle differences in the expression of certain “master regulators”, e.g.
transcription factors or secreted signaling molecules, such as cytokines,may drive the up- (or down-) regulation of whole sets of effector genes.
In line with this hypothesis, in their study across six different virus
species, Schoggins and colleagues identiﬁed as someof themost broadly
active ISGs master regulators, such as IRF1 (impacting all six viral spe-
cies), RIG-I, MDA5 and IRF7 [20,23]. In our data, one striking difference
between the cell lines was the production of several CXCL-type
chemokines in response to IFN-α and IFN-γ, which was observed in
Huh-7 but not in HuH6 cells. Furthermore, also the cytokines IL-8
(WRD 1.34 in IFN-α) and IL-7 (WRD 1.15 in IFN-γ), as well as the neg-
ative regulatory factor IRF2 (WRD 0.98 in IFN-α, WRD 0.95 in IFN-γ)
were differentially regulated between the two cell lines. It is unclear if
and to what extent these signaling modulators contribute to the ob-
served differences in ISG expression proﬁles, but the ﬁndings represent
interesting starting points for further investigations and may direct
future experimentation.Acknowledgments
This project was funded by grants from the Deutsche
Forschungsgemeinschaft (MB: BI 1693/1-1; VL: FOR1202, TP3; RB:
FOR1202, TP1). The authors would like to especially thank Rahel Klein
and Ulrike Herian for excellent technical assistance.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2015.12.017.References
[1] V. Lohmann, R. Bartenschlager, On the history of hepatitis C virus cell culture
systems. J. Med. Chem. 57 (2014) 1627–1642.
[2] M. Frese, T. Pietschmann, D. Moradpour, O. Haller, R. Bartenschlager, Interferon-
alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-
independent pathway. J. Gen. Virol. 82 (2001) 723–733.
[3] M. Frese, V. Schwarzle, K. Barth, N. Krieger, V. Lohmann, S. Mihm, O. Haller, R.
Bartenschlager, Interferon-gamma inhibits replication of subgenomic and genomic
hepatitis C virus RNAs. Hepatology 35 (2002) 694–703.
[4] M.P.Windisch, M. Frese, A. Kaul, M. Trippler, V. Lohmann, R. Bartenschlager, Dissect-
ing the interferon-induced inhibition of hepatitis C virus replication by using a novel
host cell line. J. Virol. 79 (2005) 13778–13793.
[5] P. Chomczynski, N. Sacchi, Single-stepmethod of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987).
[6] J. Durig, H. Nuckel, A. Huttmann, E. Kruse, T. Holter, K. Halfmeyer, A. Fuhrer, R.
Rudolph, N. Kalhori, A. Nusch, S. Deaglio, F. Malavasi, T. Moroy, L. Klein-Hitpass, U.
Duhrsen, Expression of ribosomal and translation-associated genes is correlated
with a favorable clinical course in chronic lymphocytic leukemia. Blood 101
(2003) 2748–2755.
[7] M.A. Kallio, J.T. Tuimala, T. Hupponen, P. Klemela, M. Gentile, I. Scheinin, M. Koski, J.
Kaki, E.I. Korpelainen, Chipster: user-friendly analysis software for microarray and
other high-throughput data. BMC Genomics 12 (2011) 507.
[8] M. Dai, P. Wang, A.D. Boyd, G. Kostov, B. Athey, E.G. Jones, W.E. Bunney, R.M. Myers,
T.P. Speed, H. Akil, S.J. Watson, F. Meng, Evolving gene/transcript deﬁnitions signif-
icantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33 (2005), e175.
[9] T. Hulsen, V.J. De, W. Alkema, BioVenn — a web application for the comparison
and visualization of biological lists using area-proportional Venn diagrams.
BMC.Genomics 9 (2008) 488.
[10] I. Rusinova, S. Forster, S. Yu, A. Kannan, M. Masse, H. Cumming, R. Chapman, P.J.
Hertzog, Interferome v2.0: an updated database of annotated interferon-regulated
genes. Nucleic Acids Res. 41 (2013) D1040–D1046.
[11] L.I. Brodsky, A.S. Wahed, J. Li, J.E. Tavis, T. Tsukahara, M.W. Taylor, A novel unsuper-
vised method to identify genes important in the anti-viral response: application to
interferon/ribavirin in hepatitis C patients. PLoS.One 2 (2007), e584.
[12] M.J. de Veer, M. Holko, M. Frevel, E. Walker, S. Der, J.M. Paranjape, R.H. Silverman,
B.R. Williams, Functional classiﬁcation of interferon-stimulated genes identiﬁed
using microarrays. J. Leukoc. Biol. 69 (2001) 912–920.
[13] C.M. Hilkens, J.F. Schlaak, I.M. Kerr, Differential responses to IFN-alpha subtypes in
human T cells and dendritic cells. J. Immunol. 171 (2003) 5255–5263.
[14] M. Hultcrantz, M.H. Huhn,M.Wolf, A. Olsson, S. Jacobson, B.R.Williams, O. Korsgren,
M. Flodstrom-Tullberg, Interferons induce an antiviral state in human pancreatic
islet cells. Virology 367 (2007) 92–101.
[15] S. Indraccolo, U. Pfeffer, S. Minuzzo, G. Esposito, V. Roni, S. Mandruzzato, N. Ferrari, L.
Anfosso, R. Dell'Eva, D.M. Noonan, L. Chieco-Bianchi, A. Albini, A. Amadori, Identiﬁ-
cation of genes selectively regulated by IFNs in endothelial cells. J. Immunol. 178
(2007) 1122–1135.
170 O. Grünvogel et al. / Genomics Data 7 (2016) 166–170[16] R.E. Lanford, B. Guerra, H. Lee, D. Chavez, K.M. Brasky, C.B. Bigger, Genomic response
to interferon-alpha in chimpanzees: implications of rapid downregulation for
hepatitis C kinetics. Hepatology 43 (2006) 961–972.
[17] D.W. Leaman, M. Chawla-Sarkar, B. Jacobs, K. Vyas, Y. Sun, A. Ozdemir, T. Yi, B.R.
Williams, E.C. Borden, Novel growth and death related interferon-stimulated
genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-
alpha2. J. Interf. Cytokine Res. 23 (2003) 745–756.
[18] M.R. Rani, J. Shrock, S. Appachi, R.A. Rudick, B.R. Williams, R.M. Ransohoff, Novel
interferon-beta-induced gene expression in peripheral blood cells. J. Leukoc. Biol.
82 (2007) 1353–1360.
[19] M. Sarasin-Filipowicz, E.J. Oakeley, F.H. Duong, V. Christen, L. Terracciano, W.
Filipowicz, M.H. Heim, Interferon signaling and treatment outcome in chronic
hepatitis C. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7034–7039.
[20] J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, P. Bieniasz, C.M. Rice, A
diverse range of gene products are effectors of the type I interferon antiviral
response. Nature 472 (2011) 481–485.[21] X.S. He, X. Ji, M.B. Hale, R. Cheung, A. Ahmed, Y. Guo, G.P. Nolan, L.M. Pfeffer, T.L.
Wright, N. Risch, R. Tibshirani, H.B. Greenberg, Global transcriptional response to
interferon is a determinant of HCV treatment outcome and is modiﬁed by race.
Hepatology 44 (2006) 352–359.
[22] O. Grunvogel, K. Esser-Nobis, A. Reustle, P. Schult, B. Muller, P. Metz, M. Trippler,
M.P. Windisch, M. Frese, M. Binder, O. Fackler, R. Bartenschlager, A. Ruggieri, V.
Lohmann, DDX60L is an interferon-stimulated gene product restricting hepatitis C
virus replication in cell culture. J. Virol. 89 (2015) 10548–10568.
[23] J.W. Schoggins, D.A. MacDuff, N. Imanaka, M.D. Gainey, B. Shrestha, J.L. Eitson, K.B.
Mar, R.B. Richardson, A.V. Ratushny, V. Litvak, R. Dabelic, B. Manicassamy, J.D.
Aitchison, A. Aderem, R.M. Elliott, A. Garcia-Sastre, V. Racaniello, E.J. Snijder, W.M.
Yokoyama, M.S. Diamond, H.W. Virgin, C.M. Rice, Pan-viral speciﬁcity of IFN-
induced genes reveals new roles for cGAS in innate immunity. Nature 505 (2014)
691–695.
